270 related articles for article (PubMed ID: 10366514)
1. Induction of beta-sheet structure in amyloidogenic peptides by neutralization of aspartate: a model for amyloid nucleation.
Orpiszewski J; Benson MD
J Mol Biol; 1999 Jun; 289(2):413-28. PubMed ID: 10366514
[TBL] [Abstract][Full Text] [Related]
2. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
4. Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet.
Ohnishi S; Koide A; Koide S
J Mol Biol; 2000 Aug; 301(2):477-89. PubMed ID: 10926522
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation.
Soto C; Kindy MS; Baumann M; Frangione B
Biochem Biophys Res Commun; 1996 Sep; 226(3):672-80. PubMed ID: 8831674
[TBL] [Abstract][Full Text] [Related]
6. Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids.
Sciarretta KL; Boire A; Gordon DJ; Meredith SC
Biochemistry; 2006 Aug; 45(31):9485-95. PubMed ID: 16878983
[TBL] [Abstract][Full Text] [Related]
7. Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides.
Maury CP; Nurmiaho-Lassila EL; Rossi H
Lab Invest; 1994 Apr; 70(4):558-64. PubMed ID: 8176895
[TBL] [Abstract][Full Text] [Related]
8. Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues.
Fraser PE; McLachlan DR; Surewicz WK; Mizzen CA; Snow AD; Nguyen JT; Kirschner DA
J Mol Biol; 1994 Nov; 244(1):64-73. PubMed ID: 7966323
[TBL] [Abstract][Full Text] [Related]
9. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
Kirkitadze MD; Condron MM; Teplow DB
J Mol Biol; 2001 Oct; 312(5):1103-19. PubMed ID: 11580253
[TBL] [Abstract][Full Text] [Related]
11. Characterizations of distinct amyloidogenic conformations of the Abeta (1-40) and (1-42) peptides.
Lim KH; Collver HH; Le YT; Nagchowdhuri P; Kenney JM
Biochem Biophys Res Commun; 2007 Feb; 353(2):443-9. PubMed ID: 17184733
[TBL] [Abstract][Full Text] [Related]
12. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
Kapurniotu A; Schmauder A; Tenidis K
J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
[TBL] [Abstract][Full Text] [Related]
14. Protein interactions and misfolding analyzed by AFM force spectroscopy.
McAllister C; Karymov MA; Kawano Y; Lushnikov AY; Mikheikin A; Uversky VN; Lyubchenko YL
J Mol Biol; 2005 Dec; 354(5):1028-42. PubMed ID: 16290901
[TBL] [Abstract][Full Text] [Related]
15. New strategy for the generation of specific D-peptide amyloid inhibitors.
Esteras-Chopo A; Pastor MT; Serrano L; López de la Paz M
J Mol Biol; 2008 Apr; 377(5):1372-81. PubMed ID: 18328503
[TBL] [Abstract][Full Text] [Related]
16. Structure of amyloid beta fragments in aqueous environments.
Takano K; Endo S; Mukaiyama A; Chon H; Matsumura H; Koga Y; Kanaya S
FEBS J; 2006 Jan; 273(1):150-8. PubMed ID: 16367755
[TBL] [Abstract][Full Text] [Related]
17. Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action.
Bartolini M; Bertucci C; Bolognesi ML; Cavalli A; Melchiorre C; Andrisano V
Chembiochem; 2007 Nov; 8(17):2152-61. PubMed ID: 17939148
[TBL] [Abstract][Full Text] [Related]
18. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.
Tenidis K; Waldner M; Bernhagen J; Fischle W; Bergmann M; Weber M; Merkle ML; Voelter W; Brunner H; Kapurniotu A
J Mol Biol; 2000 Jan; 295(4):1055-71. PubMed ID: 10656810
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides.
Rijkers DT; Höppener JW; Posthuma G; Lips CJ; Liskamp RM
Chemistry; 2002 Sep; 8(18):4285-91. PubMed ID: 12298020
[TBL] [Abstract][Full Text] [Related]
20. Direct visualisation of the beta-sheet structure of synthetic Alzheimer's amyloid.
Serpell LC; Smith JM
J Mol Biol; 2000 May; 299(1):225-31. PubMed ID: 10860734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
